Interim Clinical Considerations for Use of JYNNEOS and ACAM2000 Vaccines During the 2022 U.S. Monkeypox Outbreak: Vaccination Strategies

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
• Description:
  Two vaccines may be used for the prevention of monkeypox disease:
  
  • JYNNEOS vaccine is used for the prevention of smallpox and monkeypox disease among people determined to be at high risk for infection.
  
  • ACAM2000 vaccine is approved for immunization against smallpox disease for people determined to be at high risk for infection. It has been made available for use against monkeypox in the current outbreak.
  
  
• Content Notes:
  Vaccines -- Vaccination Strategies -- Table 1. Vaccination Strategies Used in the 2022 U.S. Monkeypox Outbreak -- Planning Considerations for Health Departments and Providers -- Health Equity -- Table of Contents -- Resources .
• Subjects:
  Mpox (monkeypox)/prevention & Control Smallpox Vaccine Vaccination
• Document Type:
  Text
• Name as Subject:
  ACAM2000® ; JYNNEOS®
• Genre:
  Webpage
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:a2eb22b91290fd2fa247253251c132fc778fed20227db5de141ccf1c1c73210a9db66fc8515bfd0018d2e40faab2685278fde1a00c253f41be50b7eb5b6b8247
• Download URL:
  https://stacks.cdc.gov/view/cdc/120087/cdc_120087_DS1.pdf
• File Type:
  [PDF - 357.04 KB ]